Bruker Launches LUMOS™ II ILIM for Enhanced Infrared Imaging in Pharma and Life Science Research

You are currently viewing Bruker Launches LUMOS™ II ILIM for Enhanced Infrared Imaging in Pharma and Life Science Research
Image used for information purposes only. Picture Credit: https://d2jx2rerrg6sh3.cloudfront.net/

Key Highlights: 

  • High Performance Infrared Imaging 
  • AI-powered Data Evaluation and Multi-modal imaging 
  • Versatile and customizable for Research Needs 

Bruker launched LUMOS II ILIM Infrared Imaging Microscope. The product is primarily used in pharma and life science research fields. Thus, it is very well adapted to the tasks described below in the following application. QCL technology drives performance to the limit for enabling researchers to obtain ultra-fast IR images with very high spatial resolution over large areas. 

It comes with patented coherence reduction method. Thus infrared imaging is almost fully artifact free whether in transmission and reflection mode. This is quite a high-field-of-view instrumentation completely automated therefore one may readily ascertain the level of chemical complexity within biological tissue within short durations but very fine quality data, all these obtained in least amount of time. 

The LUMOS II ILIM is quite unique in offering the integration of AI-powered data evaluation, aimed at streamlining workflows for life science, pharma, and disease research. It also includes MALDI Imaging methods from Bruker, that can carry out multimodal imaging for characterizing tissues with more analytical depth. Highly flexible and adaptable, the LUMOS II ILIM can handle rapid pharmaceutical tablet inspection, particle identification, or fully automated sampling. The Python interface will allow the adaptation of the microscope to users’ needs and custom research workflows. 

According to Clinical Bone Pathologist with Centre Hospitalier Universitaire Angers, Dr. Guillaume Mabilleau, infrared imaging of biological samples through a microscope is much faster, of much higher quality than traditional technologies, and so he thinks it is intuitive for him to operate it with very high throughput as well as accelerate the workflow. “That completely changes the game in clinical research, too,” said Dr. Mabilleau. Well, this actual microscope is exactly where Dr. Mabilleau’s team wants to send the diagnosis and treatment of these bone diseases. 

This will revolutionize clinical research, pharmaceutical applications, and disease research with the LUMOS ™ II ILIM, placing high performance and a highly efficient infrared imaging and chemical analysis tool firmly in the researcher’s hand.